Tag: Heeru Dingra

SAVA Healthcare appoints WATConsult as digital marketing partner for SAVA Herbals

Mumbai: Pune-based SAVA Healthcare has appointed WATConsult, the globally awarded hybrid digital agency from the house of dentsu India, as the digital marketing partner for its new herbal formulation business, ‘SAVA Herbals’. SAVA Healthcare is an Indian multinational and one of the fastest-growing pharmaceutical companies. Within a decade, the company has established a strong footprint globally as well as in India with its human and veterinary pharmaceuticals.

As per the mandate, WATConsult will oversee Social Media Management, Media Planning & Buying, Online Reputation Management and Search Engine Optimisation for the brand.

The key focus of the agency will be to drive the brand growth and complete execution of the strategies across all leading digital and social media platforms generating a high engagement rate and overall connection with the audience.

Speaking on the partnership, Vinod Ramchandra Jadhav, Chairman, SAVA Group said, “SAVA Healthcare has always believed in providing customers with the best quality pharmaceutical products. SAVA Herbals is an extension of the capabilities that we have built over the years in manufacturing herbal extracts of highest purity. We truly believe that our association with WATConsult will help us grow and set new benchmarks as we promote our brand’s philosophy of making life feel good.”

Dr Sriram Padmanabhan, Head – R&D, SAVA Healthcare added, “The products that are being launched by SAVA Herbals have been developed in-house and tested for clinical efficacy and safety in patients, which is very significant. WATConsult will help us spread this message and reach out to customers across.”

Commenting on the association, Heeru Dingra, CEO, WATConsult said, “Healthcare is of paramount importance especially in today’s times and so are companies like SAVA that intend to help improve people’s lives. Armed with a lot of new-age thinking and a digital-first approach, we are looking forward to helping the company further scale its efforts and accelerate business growth.”

Through SAVA Herbals, SAVA Healthcare will be launching clinically proven herbal product offerings across various therapy areas. The company has plans to launch more products in the next few months. These products will be available on www.savaherbals.com and all major e-commerce platforms.

WATConsult’s latest edition of WATPaper analyses the Adoption of Telemedicine & E-Pharmacy in India

Mumbai: WATConsult, the globally awarded hybrid digital agency from the house of dentsu India, has released its latest issue of WATPapers, titled ‘Adoption of Telemedicine and E-Pharmacy during the pandemic’. With the tremendous strain on the country’s healthcare system and the growing emphasis on a national lockdown, this report provides insightful details on the scope of e-pharmacies and telemedicine as well as the behaviours of those using these services.

The huge disparity between India’s vast population and the healthcare infrastructure clearly demonstrates the need for increased investment in the sector. In a challenging situation like this, telemedicine and e-pharmacies have proved to be an important tool that can curb the burden on the healthcare system by providing medical assistance without stepping out. Results suggest that 75% of the people have stated that their usage of telemedicine services have increased during the pandemic compared to the pre-pandemic situation. 43% have been using the telemedicine service because of the convenience it offers, while the rest are abiding by the COVID-19 safety protocols. Being the most vulnerable, the usage of telemedicine and e-pharmacy services is higher in the age group of 50 to 59 years.

The research noted that the majority of the people have been using telemedicine services during the COVID-19 pandemic to locate nearby hospitals/clinics to book tests, check-ups, and consultation appointments with doctors. More than 60% of the people are using telemedicine and e-pharmacy apps at least once a month. Apollo 247-online consult, Lybrate, mFine, and Practo are some of the most used telemedicine applications. Pharmacy apps like PharmEasy, BookMeds and SmartMedics have been the top choice for most people.

These innovative tech-driven services are contributing towards the future-ready digital health system in India and are empowering its people by offering affordable access to healthcare instantly. However, the major concern reported by 52% of people is around the difficulty in understanding the interface of the application.

Link: https://www.watconsult.com/watpapers/

WATConsult’s latest edition of WATPaper analyses the Adoption of Telemedicine & E-Pharmacy in India

Commenting on the current issue of WATPapers, Heeru Dingra, CEO, WATConsult said, “The COVID-19 pandemic has pushed the adoption of telemedicine and e-pharmacy services. This has opened newer avenues and opportunities for companies. Telemedicine has enabled patients to consult doctors from any part of the world, while e-pharmacy services are extremely convenient and cost-effective, as reported in this issue of WATPapers. Since this sector is at a nascent stage in India, concerns around privacy, security, negligence, interface challenges are understandable. However, I do believe in its potential to grow into a very large industry in future.”

WATPapers are monthly published short reports, based on the primary research conducted by Recogn, the agency’s research division that provides consumer and business insights to the audience. It aims to delve into the different aspects of the digital industry, consumer behaviour and more. Additionally, it also covers some relevant topics like the adoption of ‘Work from Home’ by Indians, changes in consumer spends during COVID-19 and the switch to online education during the pandemic.

WATConsult’s research vertical, Recogn, in the past, has published many detailed and comprehensive pieces of research like Digital Diverse and Multilingual India, Voice Technology in India: Now & Future, Instagram in India, to name a few.